Tomokazu Fujisawa
Director/Board Member bei ASTELLAS PHARMA INC.
Profil
Tomokazu Fujisawa ist Mitglied des Vorstands von Astellas Pharma, Inc. Zuvor war er Director-Planning & Medical Supply Business bei Fujisawa Pharmaceutical Co., Ltd.
Aktive Positionen von Tomokazu Fujisawa
Unternehmen | Position | Beginn |
---|---|---|
ASTELLAS PHARMA INC. | Director/Board Member | 15.06.2018 |
INABATA & CO.,LTD. | Director/Board Member | 22.06.2022 |
Ehemalige bekannte Positionen von Tomokazu Fujisawa
Unternehmen | Position | Ende |
---|---|---|
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
INABATA & CO.,LTD. | Distribution Services |
ASTELLAS PHARMA INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Health Technology |